“Growing Shift towards Minimally Invasive Devices”
One key trend driving the neurostimulation market is the growing shift towards minimally invasive devices that offer longer-lasting results with reduced risk and recovery time. Spinal cord stimulators and deep brain stimulators, for instance, are now being designed with advanced features such as wireless programming and closed-loop systems that automatically adjust stimulation based on real-time feedback from the body. This trend is especially evident in products such as Medtronic’s Intellis™ spinal cord stimulation system, which offers longer battery life and patient-controlled adjustments for personalized therapy. Such innovations are transforming treatment for chronic pain, Parkinson’s disease, and epilepsy, making neurostimulation therapies more effective and accessible. In addition, as wearable neurostimulators gain traction, patients benefit from non-invasive, at-home treatment options, further expanding the appeal of neurostimulation. With advancements in device technology, the market is expected to continue to grow, driven by the need for more precise, personalized, and non-surgical alternatives to traditional treatments.
